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ABSTRACT
Introduction: Main objective of any pharmaceutical scientist is to develop drug delivery system that is 
safe, effective, stable, having good patient compliance and fulfill the requirements of customers. Lead to 
a great interest of research to develop the drug delivery system that will enable to supply drug «on-de-
mand» basis. These «stimuli-responsive and intelligent» systems have been designed to deliver the drug 
on various times or at various sites in the body, according to a stimulus that is either endogenous or 
externally applied.
Objectives: This paper aim to review various researches in the field of self regulatory drug delivery 
systems in tabular form so one can utilize these finding for further development of in intelligent drug 
delivery systems. 
Method: Various physicochemical principles and chemical schemes have been applied by researchers 
to get release pattern of drug as per requirement of body. Such devices can be used for intelligent drug 
delivery needed for the treatment of many diseases like diabetes.
Results & Discussion: This type of intelligent system firstly sense the signals caused by diseaseà judge 
the magnitude of signalsà and then release the drug in direct response.
Conclusion: In this article we have discuss various innovations in the field of self regulatory drug deliv-
ery Systems and suggest that here is a lot of research scope in this field.
Keywords: Intelligent Drug delivery System; Self Regulatory; Drug Delivery Systems.
RESUMEN
Introducción: El objetivo principal de cualquier científico farmacéutico es desarrollar un sistema de ad-
ministración de fármacos que sea seguro, efectivo, estable, que cumpla con los requisitos del paciente 
y cumpla con los requisitos de los clientes. Llevar a un gran interés de investigación para desarrollar el 
sistema de entrega de medicamentos que permitirá suministrar medicamentos «a demanda». Estos siste-
mas «sensibles a estímulos e inteligentes» han sido diseñados para administrar el farmaco en varios mo-
mentos o en varios sitios en el cuerpo, de acuerdo con un estímulo endógeno o aplicado externamente.
Objetivos: Este artículo tiene como objetivo revisar diversas investigaciones en el campo de los sistemas 
autorreguladores de administración de fármacos en forma tabular para que uno pueda utilizar estos 
hallazgos para un mayor desarrollo de sistemas inteligentes de administración de fármacos.
Método: Los investigadores han aplicado varios principios fisicoquímicos y esquemas químicos para 
obtener el patrón de liberación del fármaco según las necesidades del cuerpo. Dichos dispositivos se 
pueden usar para la administración inteligente de medicamentos necesarios para el tratamiento de mu-
chas enfermedades, como la diabetes.
Resultados y discusión: Este tipo de sistema inteligente primero detecta las señales causadas por la en-
fermedad, juzga la magnitud de las señales y luego libera la droga en respuesta directa.
Conclusión: En este artículo, hemos discutido varias innovaciones en el campo de los sistemas autor-
reguladores de administración de fármacos y sugerimos que aquí hay mucho campo de investigación 
en este campo.
Palabras clave: Sistema inteligente de administración de fármacos; Autorregulador.
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INTRODUCTION 
As the traditional drug delivery systems (DDSs) often as-
sociated with many side effects, there as an always require-
ment of approaches to develop new formulations for trans-
porting medicine at required level when it needed. This 
type of on demand basis drug delivery also called smart 
drug delivery or intelligent drug delivery. These novel 
techniques enhance the therapeutic values and also reduce 
various side effects. In comparison to the conventional 
DDSs, the smart controlled DDSs can effectively reduce the 
dosage frequency, while maintaining the drug concentra-
tion in targeted organs/tissues for a longer period of time. 
In this sense, the controlled DDSs provide broad insights 
and fascinating properties for decreasing drug concentra-
tion fluctuation, reducing drug toxicities and improving 
therapeutic efficacy.1
This new class of intelligent or smart and responsive deliv-
ery systems is designed to perform various functions like 
detection, isolation and/or release of therapeutic agent for 
the treatment of various diseases. Intelligent drug delivery 
systems are mostly based on stimuli- responsive polymers 
which sense a change in a specific variable and activate the 
delivery; this phenomenon being reversible. A large num-
ber of materials such as polymers, lipids and inorganic ma-
terials, have been developed to control the drug release in 
this mannered to create smart drug delivery system. 2-7 
Benefits of intelligent drug delivery systems
1. Intelligent drug delivery systems are capable to deliver 
the drug as per the physiological needs.
2. This system help to maintain the plasma drug concen-
tration within therapeutic range. 
3. Localized delivery of drug to particular compartment 
(targeted site) can be achieve. 
4. Preserve the drugs that are rapidly destroy, enhance the 
stability. 
5. Improve patient compliance. 
MATERIAL AND METHODS
Figure 1: Intelligent drug delivery system
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TYPE OF INTELLIGENT DRUG DELIVERY SYS-
TEMS3-7
Broadly classify in two categories
1. Open-loop system: These are also known as externally 
controlled system or pulsatile systems . These system 
employed external triggers to deliver the drug such as 
magnet, temperature, ultrasound, electric effects etc. 
2. Close-loop system. These are also known as self reg-
ulated drug delivery systems or responsive systems. 
Rate of drug release controlled by feedback information 
without external intervention. These are uses various 
approached such as pH-responsive, glucose responsive, 
thermo-sensitive, urea responsive, inflammation sensi-
tive etc. 
Some are discussed below: 
a. pH-responsive system
In this type of system pH use as a trigger to release the 
drug. Alteration in pH of the environment will cause swell-
ing or de-swelling of the polymer. pH-responsive carriers 
is used to sense the pH at different region of body such as 
stomach (pH≈ 2) and intestinal tract (pH≈7).8-11
b. Redox-responsive system 
Oxidation-reduction responsive system have gained huge 
interest for disease therapy.12,13 The redox potential in mi-
croenvironments is multivariate in different tissues, which 
can be exploited to design redox-sensitive delivery sys-
tems. The design and fabrication of nanoparticles respon-
sive to Glutathione can be a promising approach for target-
ing drug delivery.14
c. Enzyme-responsive system 
Enzymes used as triggers in the design of smart drug de-
livery systems and gain attentention due to its its unique 
superiorities, such as substrate specificity and high se-
lectivity15-18. Since enzymes (such as glycosidases, lipase, 
phospoholipases or proteases) are related to almost all the 
biological and metabolic process, they can be use to get en-
zyme-mediated drug release17. 
d. Thermo responsive system
Temperature is one of the most suitable and efficient fac-
tors to control the drug release compared with other stim-
uli.19-21 Poly (acrylamide) gels swell with increasing tem-
perature, while poly(N-alkyl substituted acrylamide) gels 
deswell. Usually, disease state body temperature raised as 
compared to normal state some conditions, such as inflam-
mation and tumors, have higher temperatures than normal 
tissues [22]. By use of this temperature difference between 
cancer tissues and normal tissues, smart drug delivery can 
be use to enhance their drug release in tumors [23,24]. Anoth-
er temperature- responsive strategy is that the tumor site 
could be heated by external triggers (Ultra sound, magnet-
ic field, etc.) to improve the drug release within the tumor 
vasculature microenvironment.25 
e. Light, magnetic, and ultra sound responsive
Photo sensitive carriers are used to design light responsive 
drug delivery system and the drug release accompanied at 
desired site by external light illumination. In the magnetic 
and ultra sound responsive drug delivery system external 
magnetic field and ultra sound is used respectively to trig-
ger drug molecules at targeted site.26 
f. Other responsive systems
Glucose and other Saccharide Sensitive Systems, electro-re-
sponsive systems, Inflammation Responsive Systems, Elec-
trically Regulated Systems, Urea Responsive Delivery Sys-
tems, Morphine Triggered Naltrexone Delivery Systems, 
System Utilizing Antibody Interactions, System Utilizing 
Chelation have also been employed to control the release of 
drug from smart system. Dual stimuli-responsive DDSs are 
most common systems and have been investigated, such as 
thermo- and pH- responsive systems, redox- and pH- -re-
sponsive systems thermo- and light- responsive systems, 
ultrasonic and magnetic responsive systems.27-39
Recent advancements
Insulin Pump
The ultimate goal for diabetes mellitus is to control the 
blood glucose level by insulin delivery and minimized the 
long-term diabetic complications. Currently main therapy 
is to administered insulin through subcutaneous injection 
for diabetes patients. Two or three injections are required 
a day to maintain the normal blood glucose level. Because 
this method is burdensome and invasive to living organ-
isms, the patient’s situation would not be good regarding 
the quality of life. Therefore, an electrical and mechanical 
controlled insulin pump that injects insulin automatical-
ly into the bloodstream has been developed. An insulin 
pump constructed with polymer materials has been stud-
ied. Many researchers working on deliver insulin by smart 
device. 
Gluco Watch 
A GlucoWatch™ biographer is non-invasive, watch like de-
vice that measures glucose. A plastic part of Gluco watch 
that snaps into the biographer and sticks to the skin. Auto-
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matic reading every 10 min up to 13 hrs is taken by it. Gluco 
watch presently takes the lead among user-friendly tech-
niques aimed at glucose monitoring. This system is based 
upon the principle of reverse iontophoresis.
Stimuli-responsive drug-delivery systems in clinical 
trials: 
 – a. AuroShell: Thermosensitive gold nanoshell are pre-
pared by Nanospectra Biosciences for Intracranial tum-
ors40. 
 – b. Opaxio: Enzyme-activated polymeric NP are pre-
pared by Cell Therapeutics, Inc. for treatment of Ovarian 
cancer. 41
 – c. ThermoDox: Thermosensitive liposomal doxorubicin 
are prepared by Celsion Corporation are useful in Breast 
cancer and primary liver cancer.42 
 – d. NanoTherm: Magnetic sensitive iron oxide NPs are 
prepared by MagForce Nanotechnologies AG for Glio-
blastoma, prostata cancer, eosphageal cancer and pan-
creatic cancer.43 
RESULTS AND DISCUSSION
Current researches in the field of to intelligent drug delivery summarized here in tabular form:
Researchers / 
Year 
Title of work
Work summary and Findings 
Li et al., 
(2018)
One-Step Preparation of pH-Responsive 
Polymeric Nanogels as Intelligent Drug 
Delivery Systems for Tumor Therapy
In this work, pH-responsive polypeptide-based nanogels are re-
ported as potential drug delivery systems. At pH 7.4, MPEG-b-PN-
LG nanogels exhibit high stabilities with hydrophobic inner cores, 
which allow encapsulation of hydrophobic therapeutic agents. Un-
der tumoral acidic environments (pH ∼6.4), the cleavage of benzoic 
imine bonds induces the destruction of MPEG-b-PNLG nanogels 
and leads to rapid release of their payloads. Doxorubicin is used as 
a model drug to evaluate drug encapsulation and release.44
Zhang et al., 
(2018)
Mesoporous silica nanoparticle-based 
intelligent drug delivery system for 
bienzyme-responsive tumour targeting 
and controlled release
This paper proposes a novel type of multifunctional envelope-type 
mesoporous silica nanoparticle (MSN) to achieve cancer cell 
targeting and drug-controlled release. In this system, MSNs were 
first modified by active targeting moiety hyaluronic acid (HA) for 
breast cancer cell targeting and hyaluronidases (Hyal)-induced in-
tracellular drug release. Then gelatin, a proteinaceous biopolymer, 
was grafted onto the MSNs to form a capping layer via glutaral-
dehyde-mediated cross-linking. This system presents successful 
bienzyme-responsive targeting drug delivery in an optimal fashion 
and provides potential applications for targeted cancer therapy.45.
Zhao et al., 
(2018)
An intelligent dual stimuli-responsive 
photosensitizer delivery system with 
O2-supplying for efficient photodynam-
ic therapy
In this paper, a new type of biocompatible multifunctional photo 
sensitizer delivery system was fabricated to relieve tumor hypoxia 
and improve the efficacy of PDT.46 
Li et al., 
(2018)
Dual-responsive drug delivery systems 
prepared by blend electrospinning
Temperature and pH dual-responsive drug delivery systems 
prepared by the thermosensitive polymer poly(N-isopropylacryla-
mide) (PNIPAAm) by polymerization. It was then co-dissolved 
with the pH-sensitive polymer Eudragit® L100-55 (EL100-55) and 
processed into fibers using electrospinning. Ketoprofen, a model 
drug, was also incorporated into the composite fibers, and fibers 
based on a single polymer additionally prepared.47
Kumar et al., 
(2017)
Mesoporous silica nanoparticle based 
enzyme responsive system for colon 
specific drug delivery through guar 
gum capping
Herein, Researchers have developed a mesoporous silica nanopar-
ticle (MSN) based enzyme responsive materials for colon specific 
drug delivery. They have utilized guar gum, a natural carbohy-
drate polymer as a capping layer to contain a model drug, such 
as 5-flurouracil (5FU) within the mesoporous channels of MSN. 
The drug loaded GG-MSN system also demonstrated near perfect 
‘zero release’ property in absence of enzymes in different simulated 
conditions of the gastrointestinal tract.48
Yang et al.,
(2016)
Glucose and magnetic-responsive 
approach toward in situ nitric oxide 
bubbles controlled generation for hy-
perglycemia theranostics.
Magnetic microvesicles with glucose oxidase designed as a novel 
theranostic approach for restoring glucose homeostasis and spatio-
temporally control nitric oxide release for maintaining good overall 
diabetic health.49
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Researchers / 
Year 
Title of work
Work summary and Findings 
Stumpel et al., 
(2015)
Stimuli-Responsive Materials Based 
on Interpenetrating Polymer Liquid 
Crystal Hydrogels
Stimuli-responsive materials based on interpenetrating liquid 
crystal-hydrogel polymer networks are fabricated. These materi-
als consist of a cholesteric liquid crystalline network that reflects 
color and an interwoven poly(acrylic acid) network that provides 
a humidity and pH response. The volume change in the cross-
linked hydrogel polymer results in a dimensional alteration in the 
cholesteric network as well, which, in turn, leads to a color change 
yielding a dual-responsive photonic material.7 
Yu et al.,
(2015)
Reversal of doxorubicin resistance in 
breast cancer by mitochondria-targeted 
pH-responsive micelles.
Researchers reported an effective approach to overcome dox-
orubicin (DOX) resistance in MCF-7/ADR breast cancer using 
DOX-loaded pH-responsive micelles. The micelles were prepared 
from a pH-responsive diblock copolymer, poly(ethylene gly-
col)-block-poly(2-(diisopropylamino)ethyl methacrylate) (PEG-
b-PDPA), and a vitamin E derivate (D-α-tocopheryl polyethylene 
glycol 1000 succinate, TPGS) (denoted as PDPA/TPGS micelles).24
Nguyen et al., 
(2015)
Enzyme-Responsive Nanoparticles for 
Targeted Accumulation and Prolonged 
Retention in Heart Tissue after Myocar-
dial Infarction.
Enzyme-responsive peptide–polymer amphiphiles are assembled 
as spherical micellar nanoparticles, and undergo a morphological 
transition from spherical-shaped, discrete materials to network-like 
assemblies when acted upon by matrix metalloproteinases (MMP-2 
and MMP-9), which are up-regulated in heart tissue post-myocar-
dial infarction.36
Callmann et al., 
(2015)
Therapeutic Enzyme-Responsive Na-
noparticles for Targeted Delivery and 
Accumulation in Tumors
An enzyme responsive, paclitaxel loaded nanoparticle is described 
and assessed in vivo in a human fibrosarcoma murine xenograft. 
This work represents a proof-of-concept study demonstrating the 
utility of enzyme-responsive nanoscale drug carriers capable of 
targeted accumulation and retention in tumor tissue in response to 
overexpressed endogenous enzymes.16
Paris 
et al.,(2015)
Polymer-Grafted Mesoporous Silica Na-
noparticles as Ultrasound-Responsive 
Drug Carriers.
A new ultrasound-responsive system based on mesoporous silica 
nanoparticles was developed for biomedical applications, grafting 
a copolymer on their surface that acts as gate keeper of the pores. 
Upon ultrasound irradiation, the sensitive polymer changes its 
hydrophobicity and, therefore, its conformation toward coil-like 
opening the gates and releasing the drug.50 
Curcio et al.,
(2015)
On demand delivery of ionic drugs 
from electro-responsive CNT hybrid 
films. 
Electro-responsive hybrid hydrogel films were prepared by UV-in-
duced polymerization of Acrylamide and N,N′-ethylene bisacryla-
mide to be applied for the on/off delivery of therapeutics. Swelling 
behaviour and drug release profiles were evaluated in the presence 
of an external applied electric voltage and mathematically mod-
elled. The application of an external electric voltage resulted in a 
faster release of anionic drugs, while a slower release was recorded 
for cationic drugs.32
Alvarez-Lorenzo
et al., 
(2014)
 Smart drug delivery systems: from 
fundamentals to the clinic
This review offers a critical overview of therapeutically-interesting 
stimuli to trigger drug release and the evolution of responsive 
materials suitable as functional excipients, illustrated with recent 
examples of formulations in clinical trials or already commercially 
available, which can provide a perspective on the current state of 
the art on smart drug delivery systems.51
Liu et al.,
(2014)
pH-Sensitive nano-systems for drug 
delivery in cancer therapy.
Paper shoed that pH-Sensitive nano-systems have now been 
developed in which drug release is specifically triggered by the 
acidic tumor environment. Studies have demonstrated that novel 
pH-sensitive drug delivery systems are capable of improving the 
efficiency of cancer treatment. A number of these have been trans-
lated from bench to clinical application and have been approved 
by the food and drug administration for treatment of various 
cancerous diseases.8
6 Ars Pharm. 2018; 59(3): 1-11
Ashish Jain, Pradeep Kumar Mohanty
Researchers / 
Year 
Title of work
Work summary and Findings 
Ganesh 
et al.,
(2014)
Smart functional polymers-a new 
route towards creating a sustainable 
environment.
This review indicated recent developments in the area of smart 
functional polymers with a focus on various (physical, chemical 
and biological) stimuli responsive systems and their applications. 
Furthermore, article also provides useful insights and in-depth 
analysis on the feasibility of utilizing stimuli responsive polymeric 
materials/composites in anti-fouling and water harvesting appli-
cations which hold tremendous potential to create a sustainable 
environment.9
Torchilin 
et al.,
(2014)
Multifunctional, stimuli-sensitive nano-
particulate systems for drug delivery
Here, researchers highlighted recent developments with multifunc-
tional and stimuli-sensitive novel drug delivery systems and their 
therapeutic potential for diseases including cancer, cardiovascular 
diseases and infectious diseases.25
Chiang et al.,
(2014)
pH-responsive polymer-liposomes for 
intracellular drug delivery and tumor 
extracellular matrix switched-on target-
ed cancer therapy
In this study, ECM-targeting liposomes were completely investi-
gated their pH-responsibility, drug releasing behaviors, anticancer 
efficiencies and the time-dependent organ distribution and toxic 
effects.52
Mura et al.,
(2013)
Stimuli-responsive nanocarriers for 
drug delivery
In this Review, researchers have discussed recent advances in the 
design of nanoscale stimuli-responsive systems that are able to 
control drug biodistribution in response to specific stimuli, either 
exogenous (variations in temperature, magnetic field, ultrasound 
intensity, light or electric pulses) or endogenous (changes in pH, 
enzyme concentration or redox gradients).12
Kelley et al.,
(2013)
Stimuli-responsive copolymer solution 
and surface assemblies for biomedical 
applications.
In this review, researchers have discuss several methods that have 
been employed to synthesize self-assembling and stimuli-respon-
sive copolymers for biomedical applications, and we identify 
common themes in the response mechanisms among the targeted 
stimuli. Additionally, we highlight parallels between the chemis-
tries used for generating solution assemblies and those employed 
for creating copolymer surfaces.53
Cheng et al.,
(2013)
Dual and multi-stimuli responsive pol-
ymeric nanoparticles for programmed 
site-specific drug delivery
Researchers studied novel dual and multi-stimuli responsive poly-
meric nanoparticles that respond to a combination of two or more 
signals such as pH/temperature, pH/redox, pH/magnetic field, 
temperature/reduction, double pH, pH and diols, temperature/
magnetic field, temperature/enzyme, temperature/pH/redox, 
temperature/pH/magnetic, pH/redox/magnetic, temperature/re-
dox/guest molecules, and temperature/pH/guest molecules have 
recently been developed. These dual and multi-stimuli responsive 
polymeric nanoparticles have shown unprecedented control over 
drug delivery and release leading to superior in vitro and/or 
in vivo anti-cancer efficacy.54
Duan et al.,
(2013)
Smart pH-sensitive and temporal-con-
trolled polymeric micelles for effective 
combination therapy of doxorubicin 
and disulfiram
A smart pH-sensitive polymeric micelles system with high drug 
loading and precise drug ratio was designed and prepared by 
conjugating doxorubicin (DOX) to poly(styrene-co-maleic anhy-
dride) (SMA) derivative with adipic dihydrazide (ADH) through a 
acid-cleavable hydrazone bond, and then encapsulating disulfiram 
(DSF), a P-gp inhibitor as well as an apoptosis inducer, into the 
micelles formed by the self-assembly of SMA-ADH-DOX (SAD) 
conjugate. The pH-sensitive polymeric micelles system enabled a 
temporal release of two drugs 55 
Pan et al, 
(2012)
 Redox/pH dual stimuli-responsive 
biodegradable nanohydrogels with 
varying responses to dithiothreitol and 
glutathione for controlled drug release
A new type of redox/pH dual stimuli-responsive poly(meth-
acrylic acid) (PMAA)-based nanohydrogels was prepared from 
methacrylic acid and N,N-bis(acryloyl)cystamine crosslinker via 
distillation-precipitation polymerization. These nanohydrogels 
possess many favorable traits, such as excellent biocompatibility 
and biodegradability, minimal drug release under an extracellular 
condition (non-reductive), adequate drug loading capacity, and 
rapid drug release.56
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Researchers / 
Year 
Title of work
Work summary and Findings 
Mo et al.,
(2012)
Multistage pH-Responsive Liposomes 
for Mitochondrial-Targeted Anticancer 
Drug Delivery.
Zwitterionic oligopeptide liposomes (HHG2C18-L) containing a 
smart lipid (1,5-dioctadecyl-L-glutamyl 2-histidyl-hexahydroben-
zoic acid, HHG2C18) are developed to overcome the barriers faced 
by anticancer drugs on the route from the site of injection into 
the body to the final antitumor target within transport steps with 
multiple physiological and biological barriers. HHG2C18-L show 
the multistage pH-responsive to the tumor cell (mitochondria in 
this case).57 
Leung et al.,
(2012)
 Light-activated content release from 
liposomes
This review focuses on the development of liposome-based 
functional materials, where payload release is activated by light. 
Methods of sensitizing liposomes to light have progressed from the 
use of organic molecular moieties to the use of metallic plasmon 
resonant structures. This development has facilitated application 
of near infrared light for activation, which is preferred for its deep 
penetration and low phototoxicity in biological tissues.58
Yudina et al.,
(2011)
Ultrasound-mediated intracellular 
drug delivery using microbubbles and 
temperature-sensitive liposomes. 
In this study, ECM-targeting liposomes were completely investi-
gated their pH-responsibility, drug releasing behaviors, anticancer 
efficiencies and the time-dependent organ distribution and toxic 
effects. Experimental results indicate that ECM-targeting liposomes 
showed rapid drug releasing profiles in acidic conditions.59
Delcea et al.,
(2011)
Stimuli-responsive LbL capsules and 
nanoshells for drug delivery
Review of basic principles and recent developments in the area 
of stimuli responsive polymeric capsules and nanoshells formed 
via layer-by-layer (LbL) is presented. The stimuli can be logically 
divided into three categories: physical (light, electric, magnetic, 
ultrasound, mechanical, and temperature), chemical (pH, ionic 
strength, solvent, and electrochemical) and biological (enzymes 
and receptors). Using these stimuli, numerous functionalities of 
nanoshells have been demonstrated.60 
Zhao et al.,
(2011)
PEGylated thermo-sensitive poly 
(amidoamine) dendritic drug delivery 
systems
Researchers engineered PEGylated thermo-sensitive dendritic 
derivatives and investigated their temperature sensitivity and drug 
release behaviour therein.24
Wu et al.,
(2011)
Organization of glucose-responsive 
systems and their properties
In this review, researchers described various glucose-responsive 
systems and their properties ant their future prospectus.28 
Yun et al.,
(2011)
 Electro-responsive transdermal drug 
delivery behavior of PVA/PAA/MW-
CNT nanofibers.
The electro-responsive transdermal drug delivery system was 
prepared by electrospinning of poly(vinyl alcohol)/poly(acrylic 
acid)/multi-walled carbon nanotubes (MWCNTs) nanocomposites. 
The conductivity of nanofibers increased by increasing the content 
of MWCNTs and performing oxyfluorination with higher oxygen 
content. 30
Liu et al.,
(2010)
Magnetically sensitive alginate-tem-
plated polyelectrolyte multilayer 
microcapsules for controlled release of 
doxorubicin
Magnetically sensitive alginate-templated polyelectrolyte mul-
tilayer microcapsules were successfully synthesized by a novel 
process combining emulsification and layer-by-layer self-assembly 
techniques. The in vitro release behavior under a high-frequency 
magnetic field (HFMF) indicated that the applied HFMF acceler-
ated significantly the drug release from the microcapsules, which 
might be related to the microcapsules’ magnetic properties.61
Gao
et al.,
(2010)
pH-responsive nanoparticles for drug 
delivery
Nanoparticles whose cores become soluble or change their struc-
tures to release the carried drugs at the tumor extracellular pH or 
lysosomal pH have been developed for fast drug release into the 
extracellular fluid or cytosol. Such pH-responsive nanoparticles 
have therapeutic advantages over the conventional pH-insensitive 
counterpart.10
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Researchers / 
Year 
Title of work
Work summary and Findings 
Patel et al.,
(2008)
Enzyme-responsive snap-top covered 
silica nanocontainers
Mesoporous silica nanoparticles, capable of storing a payload 
of small molecules and releasing it following specific catalytic 
activation by an esterase, have been designed and fabricated. The 
storage and release of the payload is controlled by the presence of 
rotaxanes.62
Zhang et al.,
(2007)
Thermo and pH Dual-Responsive 
Nanoparticles for Anti-Cancer Drug 
Delivery
Thermo and pH dual-responsive nanoparticles for an anti-can-
cer drug were prepared. These nanoparticles aggregated at body 
temperature under a slightly acidic pH of 6.9 (see figure), and a 
faster drug release was found to be associated with higher temper-
ature and lower pH, both of which are advantageous for tumor-tar-
geted anti-cancer drug delivery.33
Murdan et al.,
(2003)
Electro-responsive drug delivery from 
hydrogels.
Electrically-responsive drug release is influenced by a number of 
factors such as the nature of the drug and of the gel, the experimen-
tal set-up, magnitude of the electric field etc. In this paper, electri-
cally-responsive hydrogels, response of gels to an electric field and 
electrically-stimulated drug release are discussed. 63
 
CONCLUSION
Intelligent drug deliver means deliver of drug to selective-
ly to targeted cells and tissues while leaving other healthy 
parts of the body untouched. Although research working 
on many areas to improve drug delivery to targeted site 
and therefore drug delivery systems gained wide attention 
in biomedical research due to their potential to significantly 
reduce the side effects of drugs and control the concentra-
tion and location of active drugs released in the body over 
long periods of time. Clearly new strategies for preparing 
drug delivery systems are capable of selectively releasing 
drug at targeted site will help improve many of the current 
problems in drug therapy.
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